<VariationArchive VariationID="850052" VariationName="NM_001698.3(AUH):c.197del (p.Gly66fs)" VariationType="Deletion" Accession="VCV000850052" Version="6" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-02-28" DateCreated="2020-04-15" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="836282" VariationID="850052">
      <GeneList>
        <Gene Symbol="AUH" FullName="AU RNA binding methylglutaconyl-CoA hydratase" GeneID="549" HGNC_ID="HGNC:890" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>9q22.31</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="91213823" stop="91361918" display_start="91213823" display_stop="91361918" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="93976096" stop="94124205" display_start="93976096" display_stop="94124205" Strand="-" />
          </Location>
          <OMIM>600529</OMIM>
        </Gene>
        <Gene Symbol="LOC130002059" FullName="ATAC-STARR-seq lymphoblastoid silent region 20025" GeneID="130002059" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>9q22.31</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="91361649" stop="91362088" display_start="91361649" display_stop="91362088" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_001698.3(AUH):c.197del (p.Gly66fs)</Name>
      <CanonicalSPDI>NC_000009.12:91361692:CCCC:CCC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>9q22.31</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="91361693" stop="91361693" display_start="91361693" display_stop="91361693" variantLength="1" positionVCF="91361692" referenceAlleleVCF="GC" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="94123975" stop="94123975" display_start="94123975" display_stop="94123975" variantLength="1" positionVCF="94123974" referenceAlleleVCF="GC" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>G66fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001698.2" sequenceAccession="NM_001698" sequenceVersion="2" change="c.197delG">
            <Expression>NM_001698.2:c.197delG</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.11" sequenceAccession="NC_000009" sequenceVersion="11" change="g.94123978del" Assembly="GRCh37">
            <Expression>NC_000009.11:g.94123978del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.12" sequenceAccession="NC_000009" sequenceVersion="12" change="g.91361696del" Assembly="GRCh38">
            <Expression>NC_000009.12:g.91361696del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008017.1" sequenceAccession="NG_008017" sequenceVersion="1" change="g.5232del">
            <Expression>NG_008017.1:g.5232del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001306190.2" sequenceAccession="NM_001306190" sequenceVersion="2" change="c.197del">
            <Expression>NM_001306190.2:c.197del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001293119.1" sequenceAccession="NP_001293119" sequenceVersion="1" change="p.Gly66fs">
            <Expression>NP_001293119.1:p.Gly66fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001351431.2" sequenceAccession="NM_001351431" sequenceVersion="2" change="c.-201del">
            <Expression>NM_001351431.2:c.-201del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001351432.2" sequenceAccession="NM_001351432" sequenceVersion="2" change="c.-293del">
            <Expression>NM_001351432.2:c.-293del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001351433.2" sequenceAccession="NM_001351433" sequenceVersion="2" change="c.-201del">
            <Expression>NM_001351433.2:c.-201del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001698.3" sequenceAccession="NM_001698" sequenceVersion="3" change="c.197del" MANESelect="true">
            <Expression>NM_001698.3:c.197del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001689.1" sequenceAccession="NP_001689" sequenceVersion="1" change="p.Gly66fs">
            <Expression>NP_001689.1:p.Gly66fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_449" sequenceAccession="LRG_449">
            <Expression>LRG_449:g.5232del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_449t1" sequenceAccession="LRG_449t1">
            <Expression>LRG_449t1:c.197del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1219516037" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001698.3(AUH):c.197del (p.Gly66fs) AND 3-methylglutaconic aciduria type 1" Accession="RCV001054138" Version="5">
        <ClassifiedConditionList TraitSetID="2494">
          <ClassifiedCondition DB="MedGen" ID="C0342727">3-methylglutaconic aciduria type 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-06-14" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-06-14" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2020-04-15" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">12655555</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20882351</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="2494" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">3 methylglutaconic aciduria type I</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">MGA type I</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">3 alpha methylglutaconic aciduria type I</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">3 methylglutaconyl CoA hydratase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">3MG CoA hydratase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">3-methylglutaconic aciduria type 1</ElementValue>
                <XRef ID="MONDO:0009610" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MGCA1</ElementValue>
                <XRef Type="MIM" ID="250950" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10321" />
                <XRef ID="10321" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/C5-OH.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated C5-OH Acylcarnitine, Organic Acidemias, 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/C5-OH-Elevated.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Organic Acidemias: Elevated C5-OH, 2022</CitationText>
              </Citation>
              <XRef ID="67046" DB="Orphanet" />
              <XRef ID="C0342727" DB="MedGen" />
              <XRef ID="MONDO:0009610" DB="MONDO" />
              <XRef Type="MIM" ID="250950" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7522837" SubmissionDate="2023-07-25" DateLastUpdated="2023-07-29" DateCreated="2023-07-29">
        <ClinVarSubmissionID localKey="NM_001698.2:c.197delG|MedGen:C0342727" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004020850" DateUpdated="2023-07-29" DateCreated="2023-07-29" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-06-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Variant summary: AUH c.197delG (p.Gly66AlafsX6) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant allele was found at a frequency of 2.9e-05 in 169544 control chromosomes. To our knowledge, no occurrence of c.197delG in individuals affected with AUH-related conditions and no experimental evidence demonstrating its impact on protein function have been reported. One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 and classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="AUH" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001698.2:c.197delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0342727" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13707883</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2383868" SubmissionDate="2024-02-07" DateLastUpdated="2024-02-28" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="1329896|MedGen:C0342727" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001218437" DateUpdated="2024-02-28" DateCreated="2020-04-15" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-04-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">12655555</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20882351</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 850052). This variant has not been reported in the literature in individuals affected with AUH-related conditions. This variant is present in population databases (no rsID available, gnomAD 0.01%). This sequence change creates a premature translational stop signal (p.Gly66Alafs*6) in the AUH gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in AUH are known to be pathogenic (PMID: 12655555, 20882351).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="AUH" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000009.11:g.94123975del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0342727" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14200269</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2383868" TraitType="Disease" MappingType="XRef" MappingValue="C0342727" MappingRef="MedGen">
        <MedGen CUI="C0342727" Name="3-methylglutaconic aciduria type 1" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7522837" TraitType="Disease" MappingType="XRef" MappingValue="C0342727" MappingRef="MedGen">
        <MedGen CUI="C0342727" Name="3-methylglutaconic aciduria type 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

